Isogenica is at the forefront of synthetic biology, pursuing a mission to provide the fastest, most efficient engine for therapeutic antibody discoveryRead More
Vienna, Austria | 25th March–27th 2019 Isogenica is excited to be attending Bio-Europe this year.
London, UK | 24th-25th April 2019
Isogenica will be speaking about VHH single domain antibodies generated from our LlamdA library.
Cambridge, UK, 7th January 2019
Today, Isogenica have announced an expansion of the collaboration and license agreement signed with Aro Biotherapeutics
Cambridge, UK, 3rd September 2018
Isogenica CEO will join Isogenica’s Board of Directors with immediate effect.